Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA

Clinical trial NCT00625339 · COMPLETED

Trial details

NCT number: NCT00625339
Sponsor: Yonsei University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2008-02-01
Primary completion: 2010-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.